FDA Drug recall D-1277-2020
LidoPatch (lidocaine HCl 3.6%, menthol 1.25%) Pain Relief Patch, packaged in 1 patch/box (NDC 10882-527-01)
- FDA Drug
- Class II
- ongoing
- Published 2020-06-03
On 2020-06-03 the FDA classified a Class II recall of LidoPatch (lidocaine HCl 3.6%, menthol 1.25%) Pain Relief Patch, packaged in 1 patch/box (NDC 10882-527-01) by Wuhan Bingbing Pharmaceutical, citing CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the l….
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1277-2020 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2020-05-19 |
| Published | 2020-06-03 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Wuhan Bingbing Pharmaceutical |
| Distribution | US |
Product
LidoPatch (lidocaine HCl 3.6%, menthol 1.25%) Pain Relief Patch, packaged in 1 patch/box (NDC 10882-527-01); 30 patches/box (NDC 10882-527-02 and 10882-527-04), Manufactured for: JAR Laboratories, Elmhurst, IL.
Reason
CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.
Identifiers
| code_info | Batch #: 1180103, Exp 2021.01.02; 180104, Exp 2021.01.03; 80105, Exp 2021.01.04; 180106, Exp 2021.01.05; 80107, Exp 2021.01.06. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1277-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.